Media & Events

Our participation in various global symposiums and events, gives us an opportunity to showcase to the world the entire gammut of products we offer. At Transasia Bio-Medicals Ltd., we encourage regular interactions with our business associates and partners, through seminars and conferences.
News Updates
20 JUN 2009 Transasia Scientific Seminars – Empower yourself!
Transasia Bio-Medicals Ltd. is conducting Scientific Seminars at various cities across India for the benefit of its esteemed customers. These events not only give a chance for all the invitees to understand the complexities involved in clinical interpretations of various pathological testings but also a common forum to share there ideas and personal experiences.

TSS Coimbatore

The Residency, Coimbatore in Tamil Nadu was the venue for the 2nd Transasia Scientific Seminar on 6th June 2009, where more than 100 eminent doctors participated in a symposium of informative lectures and discussions.

Dr.Sujay Prasad, Director, Anand Diagnostic Laboratory, Bengaluru explained to those present on the topic “Cell Counter Analysis of Immature Granulocytes”. He also explained the importance of “Managing Information in a Clinical Lab”

Mr.Sunil Dhadkar, Product Manager – Biochemistry Instruments, in his presentation on Fully Automated Analyzers in Clinical Chemistry,  emphasised on the features of EM200 – our fully automated, random access, clinical chemistry analyzer.

A presentation on the Role of Laboratory Assessment in Differential Diagnosis of Acute Coronary Syndrome was made by Mr. Sayantan Barat, Product Manager – Biochemistry Reagents, which was followed by the launch of Cardiac Markers – ErbaQik Troponin I and Cardiac Duo. He also stressed on the Importance of External Quality Assurance and EMQAS programme by Transasia Bio-Medicals Ltd.

TSS Patna

Hotel Chanakya @ Patna was the setting for the 3rd Transasia Scientific Seminar on the 20th of June 2009.
Dr. Renu Saxena, Professor and Head, Department of Haematology – All India Institute of Medical Sciences, gave a presentation on “Approach to Bleeding Disorders and Interpretation of Automated Cell Counter Parameters”

This educative seminar by Dr.Saxena was followed by presentation on EM200 AND Cardiac markers by Transasia product managers.

TSS Pune

Dr. Swati Pai from the Department of Lab Medicine, Manipal Hospital, Bengaluru was one of the guest speakers at the seminar conducted by Transasia at The Pride Hotel, Pune on the 25th of July 2009.
Dr.Pai explained to the delegates about various aspects of “Laboratory Diagnosis of Thrombophilia” and the appropriate tests to be performed to envisage a clinical presentation.

The second guest speaker of the day was Dr. Parag Dharap of Dr.Dharap’s Diagnostic centre, Mumbai. In his talk on “Quest for Automation”, Dr.Dharap highlighted the prerequisites that every lab must follow for selection of  Fully Automated Instrumentation in Biochemistry.

ICRA assigns Highest rating to the Bank lines of Transasia Bio-Medicals Limited
IRCAICRA has assigned A1+ (pronounced A one plus) indicating the highest credit quality to short term debt instruments and LAA- (pronounced as L double A minus) indicating high credit quality to long term debt instruments rating to the Rs. 200 million fund based and non-fund based limits of Transasia Bio-Medicals Limited (Transasia).

 The assigned ratings take into account Transasia’s leadership position in the domestic IVD (In-Vitro diagnostics) market with strong promoter background and management expertise. Transasia has pan India marketing and distribution network with strong focus on after sales service which is a source of competitive advantage. The company has exclusive tie-ups with international players like Sysmex, Diesse, Medica for advance IVD equipment and cater to all segments comprising of private hospitals and labs, public hospitals and Government owned entities. The financial risk profile of the company is very strong with relatively higher profitability and return on capital employed. The company is debt free and has strong liquidity in the form of investments generated out of past profits.

About the company :

Transasia Bio-Medicals Limited (‘Transasia’ or ‘the Company’) was founded by Mr Suresh Vazirani in 1985. Today, the Company is recognized as a largest player in the Diagnostic world. It has the largest Sales and Installation base with over 15,000 installations all over the country. In collaboration with leading International companies like Sysmex, Medica, Grifols, Diesse, Fujirebio and others it offers an extensive range of products in the In-Vitro Diagnostics (‘IVD’) space. Transasia is the only Indian Manufacturing & Exporting Company for sophisticated Biochemistry Analyzers. The Company sells its produce in domestic market as well as exports to 55 countries. The Company manufactures entire range of Clinical Chemistry Analysers, Elisa Readers and Microplates, Readers. Manufacturing is undertaken at 3 units, at Daman, SEEPZ and Baddi. All units are ISO 9001:2000 & ISO 13485: 2003 certified. The Company is head quartered in Mumbai and has offices across India with a team of 102 service engineers & over 250 sales engineers.